- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
French Innovative Leukemia Organisation가 후원하는 임상 시험
총 69 건
-
French Innovative Leukemia Organisation종료됨
-
French Innovative Leukemia Organisation완전한
-
French Innovative Leukemia Organisation완전한
-
French Innovative Leukemia Organisation완전한
-
French Innovative Leukemia Organisation모집하지 않고 적극적으로
-
French Innovative Leukemia Organisation완전한
-
French Innovative Leukemia Organisation완전한B 세포 만성 림프 구성 백혈병프랑스
-
French Innovative Leukemia Organisation종료됨
-
French Innovative Leukemia Organisation모병
-
French Innovative Leukemia Organisation모병
-
French Innovative Leukemia Organisation모병
-
French Innovative Leukemia Organisation완전한
-
French Innovative Leukemia OrganisationAmgen완전한
-
French Innovative Leukemia OrganisationAcute Leukemia French Association아직 모집하지 않음
-
French Innovative Leukemia OrganisationAcute Leukemia French Association아직 모집하지 않음
-
French Innovative Leukemia OrganisationAcute Leukemia French Association완전한재발성 성인 AML | 난치성 AML | FLT3-TKD 돌연변이 | FLT3-ITD프랑스
-
French Innovative Leukemia OrganisationAmgen완전한
-
French Innovative Leukemia OrganisationAcute Leukemia French Association모병AML, 성인 | 재발성 성인 AML | 난치성 AML | FLT3-TKD 돌연변이 | FLT3-ITD프랑스
-
French Innovative Leukemia OrganisationFresenius Kabi완전한
-
French Innovative Leukemia OrganisationCelgene Corporation완전한
-
French Innovative Leukemia OrganisationNovartis Pharmaceuticals모집하지 않고 적극적으로
-
French Innovative Leukemia OrganisationNovartis Pharmaceuticals종료됨
-
French Innovative Leukemia OrganisationJanssen, LP모집하지 않고 적극적으로재발성 또는 불응성 만성 림프구성 백혈병프랑스
-
French Innovative Leukemia OrganisationNovartis Pharmaceuticals완전한
-
French Innovative Leukemia OrganisationRoche Pharma AG완전한
-
University Hospital, AngersFrench Innovative Leukemia Organisation알려지지 않은
-
French Innovative Leukemia OrganisationHoffmann-La Roche완전한
-
French Innovative Leukemia OrganisationHoffmann-La Roche모병
-
French Innovative Leukemia OrganisationUniversity Hospital, Lille모병
-
French Innovative Leukemia OrganisationBristol-Myers Squibb완전한
-
University Hospital, ToulouseFrench Innovative Leukemia Organisation완전한
-
French Innovative Leukemia OrganisationLymphoma Study Association완전한
-
French Innovative Leukemia OrganisationMundipharma Pte Ltd.완전한
-
University Hospital, GrenobleFrench Innovative Leukemia Organisation완전한
-
French Innovative Leukemia OrganisationNovartis; Schering SA완전한
-
The Lymphoma Academic Research OrganisationFrench Innovative Leukemia Organisation완전한
-
French Innovative Leukemia OrganisationAcute Leukemia French Association; French Intergroup of Myeloproliferative syndromes모병
-
French Innovative Leukemia OrganisationFrench Intergroup of Myeloproliferative syndromes완전한
-
French Innovative Leukemia OrganisationGenzyme, a Sanofi Company; Acute Leukemia French Association종료됨
-
French Innovative Leukemia OrganisationAbbVie; Janssen-Cilag Ltd.모집하지 않고 적극적으로중간 위험도 만성 림프 구성 백혈병 | 환자에게 적합 | 위험 적응 및 MRD 기반 전략프랑스